These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28422142)

  • 1. G protein-coupled KISS1 receptor is overexpressed in triple negative breast cancer and promotes drug resistance.
    Blake A; Dragan M; Tirona RG; Hardy DB; Brackstone M; Tuck AB; Babwah AV; Bhattacharya M
    Sci Rep; 2017 Apr; 7():46525. PubMed ID: 28422142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KISS1/KISS1R and Breast Cancer: Metastasis Promoter.
    Guzman S; Brackstone M; Wondisford F; Babwah AV; Bhattacharya M
    Semin Reprod Med; 2019 Jul; 37(4):197-206. PubMed ID: 31972865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein-coupled kisspeptin receptor induces metabolic reprograming and tumorigenesis in estrogen receptor-negative breast cancer.
    Dragan M; Nguyen MU; Guzman S; Goertzen C; Brackstone M; Dhillo WS; Bech PR; Clarke S; Abbara A; Tuck AB; Hess DA; Pine SR; Zong WX; Wondisford FE; Su X; Babwah AV; Bhattacharya M
    Cell Death Dis; 2020 Feb; 11(2):106. PubMed ID: 32034133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse Correlation of KISS1 and KISS1R Expression in Triple-negative Breast Carcinomas from African American Women.
    Qasim M; Ricks-Santi LJ; Naab TJ; Rajack F; Beyene D; Abbas M; Kassim OO; Copeland RL; Kanaan Y
    Cancer Genomics Proteomics; 2022; 19(6):673-682. PubMed ID: 36316037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C α is involved in the regulation of AXL receptor tyrosine kinase expression in triple-negative breast cancer cells.
    Yue CH; Liu LC; Kao ES; Lin H; Hsu LS; Hsu CW; Lin YY; Lin YS; Liu JY; Lee CJ
    Mol Med Rep; 2016 Aug; 14(2):1636-42. PubMed ID: 27357025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KISS1 and KISS1R expression in primary and metastatic colorectal cancer.
    Matthaiou S; Kostakis ID; Kykalos S; Machairas N; Spartalis E; Ntikoudi E; Lambropoulou M; Karayiannakis A; Machairas N
    J BUON; 2018; 23(3):598-603. PubMed ID: 30003725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β/activin signaling promotes CDK7 inhibitor resistance in triple-negative breast cancer cells through upregulation of multidrug transporters.
    Webb BM; Bryson BL; Williams-Medina E; Bobbitt JR; Seachrist DD; Anstine LJ; Keri RA
    J Biol Chem; 2021 Oct; 297(4):101162. PubMed ID: 34481843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Kisspeptin (KISS1) and its Receptor GPR54 (KISS1R) in Prostate Cancer.
    Xoxakos I; Petraki C; Msaouel P; Armakolas A; Grigorakis A; Stefanakis S; Koutsilieris M
    Anticancer Res; 2020 Feb; 40(2):709-718. PubMed ID: 32014912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined inhibition of AXL, Lyn and p130Cas kinases block migration of triple negative breast cancer cells.
    Pénzes K; Baumann C; Szabadkai I; Orfi L; Kéri G; Ullrich A; Torka R
    Cancer Biol Ther; 2014; 15(11):1571-82. PubMed ID: 25482942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The matrix protein Fibulin-3 promotes KISS1R induced triple negative breast cancer cell invasion.
    Noonan MM; Dragan M; Mehta MM; Hess DA; Brackstone M; Tuck AB; Viswakarma N; Rana A; Babwah AV; Wondisford FE; Bhattacharya M
    Oncotarget; 2018 Jul; 9(53):30034-30052. PubMed ID: 30046386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Talazoparib nanoparticles for overcoming multidrug resistance in triple-negative breast cancer.
    Guney Eskiler G; Cecener G; Egeli U; Tunca B
    J Cell Physiol; 2020 Sep; 235(9):6230-6245. PubMed ID: 32017076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl.
    Dine JL; O'Sullivan CC; Voeller D; Greer YE; Chavez KJ; Conway CM; Sinclair S; Stone B; Amiri-Kordestani L; Merchant AS; Hewitt SM; Steinberg SM; Swain SM; Lipkowitz S
    Breast Cancer Res Treat; 2016 Jan; 155(2):235-51. PubMed ID: 26759246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Friend or foe: ABCG2, ABCC1 and ABCB1 expression in triple-negative breast cancer.
    Nedeljković M; Tanić N; Prvanović M; Milovanović Z; Tanić N
    Breast Cancer; 2021 May; 28(3):727-736. PubMed ID: 33420675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerating AXL targeting for TNBC therapy.
    Khera L; Lev S
    Int J Biochem Cell Biol; 2021 Oct; 139():106057. PubMed ID: 34403827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
    Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
    J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of Oestrogen Receptor Expression in Breast Cancer Cells Does Not Correlate with Kisspeptin Signalling and Migration.
    Azubuike UF; Newton CL; van den Bout I
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic regulation of invasion by STAT3 in triple negative breast cancer.
    McDaniel JM; Varley KE; Gertz J; Savic DS; Roberts BS; Bailey SK; Shevde LA; Ramaker RC; Lasseigne BN; Kirby MK; Newberry KM; Partridge EC; Jones AL; Boone B; Levy SE; Oliver PG; Sexton KC; Grizzle WE; Forero A; Buchsbaum DJ; Cooper SJ; Myers RM
    Oncotarget; 2017 Jan; 8(5):8226-8238. PubMed ID: 28030809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KiSS1 gene as a novel mediator of TGFβ-mediated cell invasion in triple negative breast cancer.
    Tian J; Al-Odaini AA; Wang Y; Korah J; Dai M; Xiao L; Ali S; Lebrun JJ
    Cell Signal; 2018 Jan; 42():1-10. PubMed ID: 28988968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Expression of KISS1 and KISS1 Receptor in Human Granulosa Lutein Cells-Potential Pathogenesis of Polycystic Ovary Syndrome.
    Hu KL; Zhao H; Min Z; He Y; Li T; Zhen X; Ren Y; Chang HM; Yu Y; Li R
    Reprod Sci; 2019 Nov; 26(11):1429-1438. PubMed ID: 30595091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Landscape of AXL Receptor Kinase in Triple-Negative Breast Cancer.
    Ozyurt R; Ozpolat B
    Mol Cancer Ther; 2023 Jul; 22(7):818-832. PubMed ID: 37028809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.